Humana’s CenterWell pharmacy will dispense GLP-1 weight loss drugs made by Eli Lilly as part of a new program for employers to help their workers manage obesity.
This week’s Current Climate newsletter also looks at the AI boom’s water problem and stabilized funding for the California High-Speed Rail project.
Discontinuing obesity medicines means the weight comes back and people lose the cardiovascular and metabolic benefits conferred by the drugs.
B.Grimm Power—controlled by Thai billionaire Harald Link—has bought a stake in U.S.-based hydropower operator New England Reliable Hydropower Holdings for 7.24 billion baht ($230 million) amid the group’s drive to expand its overseas renewable energy p…
Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to treat it, is preparing to file for FDA approval.
AI giving out mental health advice can be impacted by non-related fine-tuning in other narrow areas. A curious and bad outcome. An AI Insider analysis and scoop.
Looking for help with today’s New York Times Wordle? Here are some expert hints, clues and commentary to help you solve today’s Wordle and sharpen your guessing game.
Looking for help with today’s New York Times Pips? We’ll walk you through today’s puzzle and help you match dominoes to tiles.
GameStop CEO Ryan Cohen is in line to potentially earn $35 billion in stock options, so long as the company hits a $100 billion market cap. One way to hit that target is by cutting costs, and one way of cutting costs is to close down a bunch of stores. The company closed 590 stores […]
America’s AI boom is driving a surge in data center construction—along with rising water demand. Why water is becoming the hidden constraint on AI infrastructure.